Press releases

Press releases

World Alzheimer’s Day- using AI to diagnose early stages of the disease

It is World's Alzheimer's Day today. Professor Andrew Doig and Dr. Farid Khan discuss how clinical data and biomarker data can be combined using machine learning to diagnose early stages of Alzheimer's Disease. See the Guardian Article out today. Molecular and cellular changes to the brain are known to start decades [...]

21 September 2023|

PharmaKure and APIS Assay Technologies Sign a Collaboration for the Development of Clickmers related to Neurodegenerative Diseases.

Manchester, UK, 3rd July 2023: PharmaKure, a company specialising in companion diagnostics for the treatment of neurological diseases and APIS Assay Technologies Ltd, a company with scientific expertise in biomarker translation, molecular diagnostics and bioinformatics have entered into a collaboration to progress a development project for the use of Clickmers [...]

3 July 2023|

PharmaKure completes the acquisition of the CynapseDx Business with Financing involving the UK Government Future Fund.

March 26th 2021. PharmaKure is delighted to announce the completion of the acquisition of the CynapseDx assays for oligomeric proteins. This is the final step that secured invesment of £4 million from a private investor and the UK Future Fund to finance clinical trials on their leading drug candidate PK051 for Alzheimer's disease.

26 March 2021|
Go to Top